Cue Biopharma, Inc..
CUE.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing a novel class of injectable biologics called Immuno-STATs (Selective Targeting and Activation Recombinant T-cells). These Immuno-STATs are designed to selectively engage and modulate the human immune system to fi...Show More
Better Health for All
0
No evidence available to assess Cue Biopharma, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing drug therapies. The 'Fair Money & Economic Opportunity' value and its associated KPIs are designed to assess financial institutions and companies involved in lending, insuring, moving, or storing money for consumers. Cue Biopharma's core business activities, such as drug development, clinical trials, and collaboration agreements, do not involve offering financial services or products to consumers. Therefore, all KPIs within this rubric are not applicable to the company's operations, and no relevant evidence was found in the provided articles to score any of them.
Fair Pay & Worker Respect
0
No evidence available to assess Cue Biopharma, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No specific, concrete evidence regarding Cue Biopharma's fair trade and ethical sourcing practices, such as fair-trade certifications, supplier audit frequency, forced/child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, materials risk index, or supplier diversity spend, was found in the provided articles.
1
Honest & Fair Business
-40
Cue Biopharma adopted a Code of Business Conduct and Ethics on December 1, 2017.
1
This code includes a whistleblower policy that offers anonymous reporting options and explicitly prohibits retaliation.
2
However, there is no evidence regarding independent investigation processes, training frequency, or the overall effectiveness of the program. The company also has an anti-corruption policy that addresses FCPA compliance, payments to government officials, and lobbying.
3
While the policy is in place, there is no information provided on the frequency of training or metrics to assess its effectiveness.
Kind to Animals
0
The provided articles offer no specific, concrete data points to assess Cue Biopharma, Inc. against the 'Kind to Animals' ethical value. While one article indicates the company engages in animal testing, it provides no quantitative data on the volume of animals used, details on policies, or information regarding alternative methods.
1
The company's annual report explicitly states a lack of data for all relevant animal welfare KPIs.
2
No War, No Weapons
0
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing injectable biologics to treat cancer, infectious diseases, and autoimmune disorders.
1
The company's 2021 annual report explicitly states that its business activities are not applicable to arms or defense contracts.
2
Its core operations, including collaborations with Merck, LG Chem, and Boehringer Ingelheim, are centered on biopharmaceutical research and development for medical treatments.
3
There is no evidence of involvement in dual-use technologies with military applications, sales to embargoed regimes, defense-related lobbying, or any other activities related to the arms industry or conflict zones.
4
Planet-Friendly Business
0
No specific, quantitative evidence was found in the provided articles for Cue Biopharma, Inc. regarding any of the Planet-Friendly Business KPIs. The articles primarily discuss general industry trends or provide data for other pharmaceutical companies, without mentioning Cue Biopharma's environmental performance, targets, or initiatives. Article 5 mentions a 'Net Impact Ratio' for CUE.US.
1
but this metric does not align with any of the defined KPIs for Planet-Friendly Business, which focus on specific environmental metrics like emissions, renewable energy, water use, or waste diversion.
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles regarding Cue Biopharma's engagement with local or indigenous communities, cultural impact assessments, community investment, grievance mechanisms, or any other metrics related to 'Respect for Cultures & Communities'. The articles primarily focus on clinical trials, company leadership, and an expanded access policy for investigational therapies, without addressing the specified ethical value.
Safe & Smart Tech
0
No evidence available to assess Cue Biopharma, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, quantitative data was found across the provided articles regarding Cue Biopharma, Inc.'s waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero-waste certifications, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education. Several articles explicitly state the absence of such data.
1
While one article mentions contractual requirements for hazardous materials handling and environmental health and safety training in a lease agreement,
2
this does not provide measurable outcomes or specific initiatives by Cue Biopharma relevant to the hazardous waste management KPI's scoring tiers.